These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26606897)

  • 1. Analytical characterization of four new ortho-methoxybenzylated amphetamine-type designer drugs.
    Westphal F; Girreser U; Waldmüller D
    Drug Test Anal; 2016 Sep; 8(9):910-9. PubMed ID: 26606897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano liquid chromatography-high-resolution mass spectrometry for the identification of metabolites of the two new psychoactive substances N-(ortho-methoxybenzyl)-3,4-dimethoxyamphetamine and N-(ortho-methoxybenzyl)-4-methylmethamphetamine.
    Caspar AT; Meyer MR; Westphal F; Weber AA; Maurer HH
    Talanta; 2018 Oct; 188():111-123. PubMed ID: 30029353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometric properties of N-(2-methoxybenzyl)-2-(2,4,6-trimethoxyphenyl)ethanamine (2,4,6-TMPEA-NBOMe), a new representative of designer drugs of NBOMe series and derivatives thereof.
    Shevyrin V; Kupriyanova O; Lebedev AT; Melkozerov V; Eltsov O; Shafran Y; Morzherin Y; Sadykova R
    J Mass Spectrom; 2016 Oct; 51(10):969-979. PubMed ID: 27388323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gas Chromatography Mass Spectrometry (GC-MS) for Identification of Designer Stimulants Including 2C Amines, NBOMe Compounds, and Cathinones in Urine.
    Ketha H; Webb M; Clayton L; Li S
    Curr Protoc Toxicol; 2017 Nov; 74():4.43.1-4.43.10. PubMed ID: 29117432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of the NBOMes: 25C- and 25B- Sold as 25I-NBOMe.
    Laskowski LK; Elbakoush F; Calvo J; Exantus-Bernard G; Fong J; Poklis JL; Poklis A; Nelson LS
    J Med Toxicol; 2015 Jun; 11(2):237-41. PubMed ID: 25387562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of five substituted phenethylamine derivatives 5-MAPDB, 5-AEDB, MDMA methylene homolog, 6-Br-MDMA, and 5-APB-NBOMe.
    Liu C; Jia W; Qian Z; Li T; Hua Z
    Drug Test Anal; 2017 Feb; 9(2):199-207. PubMed ID: 26856255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs.
    Zuba D; Sekuła K
    Drug Test Anal; 2013 Aug; 5(8):634-45. PubMed ID: 22936468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques.
    Caspar AT; Westphal F; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2018 Jan; 410(3):897-912. PubMed ID: 28762065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues (designer drugs).
    Rösner P; Quednow B; Girreser U; Junge T
    Forensic Sci Int; 2005 Mar; 148(2-3):143-56. PubMed ID: 15639609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of (2-aminopropyl)benzofuran (APB) phenyl ring positional isomers in internet purchased products.
    Stanczuk A; Morris N; Gardner EA; Kavanagh P
    Drug Test Anal; 2013 Apr; 5(4):270-6. PubMed ID: 23349125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic fate, mass spectral fragmentation, detectability, and differentiation in urine of the benzofuran designer drugs 6-APB and 6-MAPB in comparison to their 5-isomers using GC-MS and LC-(HR)-MS(n) techniques.
    Welter J; Brandt SD; Kavanagh P; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 May; 407(12):3457-70. PubMed ID: 25711990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid chromatography-quadrupole time-of-flight mass spectrometry for screening in vitro drug metabolites in humans: investigation on seven phenethylamine-based designer drugs.
    Lai FY; Erratico C; Kinyua J; Mueller JF; Covaci A; van Nuijs AL
    J Pharm Biomed Anal; 2015 Oct; 114():355-75. PubMed ID: 26112925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe.
    Tang MH; Ching CK; Tsui MS; Chu FK; Mak TW
    Clin Toxicol (Phila); 2014 Jun; 52(5):561-5. PubMed ID: 24779864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MS-Based Molecular Networking of Designer Drugs as an Approach for the Detection of Unknown Derivatives for Forensic and Doping Applications: A Case of NBOMe Derivatives.
    Yu JS; Seo H; Kim GB; Hong J; Yoo HH
    Anal Chem; 2019 May; 91(9):5483-5488. PubMed ID: 30990678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MS(n) techniques.
    Welter J; Kavanagh P; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 Feb; 407(5):1371-88. PubMed ID: 25471293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic effects of psychotropic benzofuran derivatives, N-methyl-5-(2-aminopropyl)benzofuran and its N-demethylated derivative, on isolated rat hepatocytes.
    Nakagawa Y; Suzuki T; Tada Y; Inomata A
    J Appl Toxicol; 2017 Mar; 37(3):243-252. PubMed ID: 27291301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of six 'neuro-enhancing' phenidate analogs.
    Klare H; Neudörfl JM; Brandt SD; Mischler E; Meier-Giebing S; Deluweit K; Westphal F; Laussmann T
    Drug Test Anal; 2017 Mar; 9(3):423-435. PubMed ID: 28067464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural elucidation of an uncommon phenylethylamine analogue in urine responsible for discordant amphetamine immunoassay results.
    Marson C; Schneider S; Meys F; Wennig R
    J Anal Toxicol; 2000; 24(1):17-21. PubMed ID: 10654564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS.
    Maresová V; Chadt J; Prikryl L
    Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():121-4. PubMed ID: 17159795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of 2,5-dimethoxy-3,4-dimethyl-β-phenethylamine (2C-G)--a new designer drug.
    Zuba D; Sekuła K
    Drug Test Anal; 2013 Jul; 5(7):549-59. PubMed ID: 22927304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.